Target intelligence / Profile preview

Tubulin beta class I pseudogene 9 (TUBBP9)

Target
TUBBP9
Molecular classification
Other (Pseudogene)
01

Overview

Tubulin beta class I pseudogene 9 (TUBBP9) is a processed pseudogene related to the tubulin beta class I (TUBB) gene. Pseudogenes are genomically encoded DNA sequences that resemble known protein-coding genes but lack the capacity to encode functional proteins due to disabling mutations, missing regulatory elements, or truncations. The TUBB gene encodes beta tubulin, a major component of microtubules, but TUBBP9 is a non-functional, non-coding copy. There is no evidence that TUBBP9 produces a functional protein or acts as a therapeutic drug target. Pseudogenes were historically categorized as “genomic fossils,” but some have regulatory or non-coding RNA functions; however, there is no available evidence that TUBBP9 has such functions. Tubulin beta class I (TUBB) itself is a key structural microtubule protein, but TUBBP9 is only a pseudogene copy. Pseudogenes may sometimes regulate parental genes via miRNA decoy activity or ceRNA mechanisms, but these roles are gene-specific and, in the case of TUBBP9, there is no published evidence for such activity. Key points: - TUBBP9 is not a protein, enzyme, receptor, or other classical druggable target. - TUBBP9 is not known to be associated with any diseases, biomarkers, or drug interactions. - There is no safety or therapeutic concern because it is not an expressed, functional target. If you need structured information on the actual functional target, you likely seek Tubulin beta class I (TUBB), not TUBBP9.

Other names
TUBBP9

Beyond the preview

Go deeper on Tubulin beta class I pseudogene 9 (TUBBP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin beta class I pseudogene 9 (TUBBP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call